Ohio media: Gov. DeWine orders post-release control review
UC criminal justice professor appointed by Ohio governor as part of select committee to reexamine statewide policies on post-release control supervision of felony inmates
Ed Latessa, professor of criminal justice and director of the University of Cincinnati’s School of Criminal Justice, is among nine professionals named by Ohio Gov. Mike DeWine to a working group to review statewide policies on post-release control supervision of felony inmates who have served their sentences. DeWine, who announced his Governor’s Working Group Oct. 28, said the committee will review and recommend improvements to the Ohio Adult Parole Authority’s post-release control supervision practices in Ohio. The move, the governor said, was prompted by concerns that current policies aren’t “strong enough” to monitor offender recidivism and protect the public.
Read the Ohio release here.
Read more in the Toledo Blade, Dayton 24/7 Now or WBNS in Columbus.
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.